Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.64M$1.64Mderived+8.2% vs Q4 2015 Net Income-$1.68M-$1.68MderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,790,259N/M Operating Cash Flowderived-$1,111,886N/M Free Cash Flowderived-$1,112,564N/M Margins · derivedOperating margin-109.5%−15.6 pt vs Q4 2015
Net margin-102.8%−23.5 pt vs Q4 2015
ended Dec 31, 2016 · filed Mar 9, 2017 · 68 d after period end